EUVIMEDEUVIMED entdecken
EditorialOpen Access · CC BY-NC 4.0

Rare pediatric tumors benefit from large clinical trials: The story of undifferentiated embryonal sarcoma of the liver

Max M van Noesel iD

Cancer · 2024

DOI: 10.1002/cncr.35327 ↗

Kurz gefasst

Editorial in der Zeitschrift Cancer, 2024. Verfasst von Max M van Noesel. Beteiligte Einrichtung: Department of Solid Tumors, Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands. Hauptthemen laut MEDLINE: Liver Neoplasms, Neoplasms, Germ Cell and Embryonal, Sarcoma. Die Arbeit nennt 7 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

This editorial provides a comprehensive summary of two clinical trials on undifferentiated embryonal sarcoma of the liver from the major sarcoma groups in the American Children’s Oncology Group and the European Paediatric Soft Tissue Sarcoma Study Group.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Liver NeoplasmsNeoplasms, Germ Cell and EmbryonalSarcomaChildHumansClinical Trials as Topic

Autor:innen und Institutionen

  • Department of Solid Tumors, Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.

ORCID-Profile: Max M van Noesel

Zitieren

APA

van Noesel, M. M. (2024). Rare pediatric tumors benefit from large clinical trials: The story of undifferentiated embryonal sarcoma of the liver. Cancer. https://doi.org/10.1002/cncr.35327

Vancouver

van Noesel MM. Rare pediatric tumors benefit from large clinical trials: The story of undifferentiated embryonal sarcoma of the liver. Cancer. 2024. doi:10.1002/cncr.35327

BibTeX
@article{vanNoesel2024,
  author = {van Noesel, Max M},
  title = {Rare pediatric tumors benefit from large clinical trials: The story of undifferentiated embryonal sarcoma of the liver},
  journal = {Cancer},
  year = {2024},
  doi = {10.1002/cncr.35327}
}
Kostenlos starten →